FDA Inspection 1165123 — The Ritedose Corporation

The Ritedose Corporation — FEI 3001237796

The FDA completed an inspection of The Ritedose Corporation on Mar 22, 2022 in Columbia, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbia, SC (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.